๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Theoretical perspectives on language and communication problems in mental retardation and developmental disabilities

โœ Scribed by Abbeduto, Leonard ;Evans, Julia ;Dolan, Terrence


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
157 KB
Volume
7
Category
Article
ISSN
1080-4013

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Beta-adrenergic blockers in mental retar
โœ Ruedrich, Stephen ;Erhardt, Lendita ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB ๐Ÿ‘ 2 views

Beta-adrenergic-blocking medications have been hypothesized to benefit persons with a wide variety of neuropsychiatric disorders. Research supports their use in only three areas, however: anxiety disorders with prominent physiological signs, impulsive aggression, and neuroleptic-induced akathisia (N

Drug-behavior interactions in persons wi
โœ Napolitano, Deborah A. ;Jack, Susan L. ;Sheldon, Jan B. ;Williams, Dean C. ;McAd ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB ๐Ÿ‘ 2 views

Treatment for aberrant behavior in persons diagnosed with developmental disabilities typically involves either behavioral interventions or medication. Often, the treatment is a combination of the two. Schroeder and coworkers Adv Learn Behav Disabil 2:179-225) outlined criteria for the evaluation of

Measuring side effects of psychopharmaco
โœ Kalachnik, John E. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 173 KB ๐Ÿ‘ 2 views

To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p